Hemiplegic Migraine Associated With Variations: A Clinical and Genetic Study.

Neurology

From the Service de Génétique Moléculaire (F.R., C. Barbance, J.H., E.T.-L.), Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris; INSERM UMR-S1141 (F.R., E.T.-L.), Université Paris; Emergency Headache Centre (C. Roos), Lariboisière Hospital, Paris; INM (A.R.), Univ Montpellier, INSERM, CHU Montpellier, Département de Neuropédiatrie; Service de Neurologie Pédiatrique (S.A.), Hôpital Robert Debré, Assistance Publique des Hôpitaux de Paris; Service de Neurologie et Pathologie du Mouvement (G.B.), CHRU de Lille; Pain Department (M.B., A. Donnet, S.R.), FHU INNOVPAIN, Hôpital La Timone, Marseille; Equipe Douleur et Soins Palliatifs Pédiatriques (C. Boulanger), Hôpital des Enfants, CHU Toulouse; Service de Neuropédiatrie (A.C.), Centre Hospitalier d'Arras; Service de Pédiatrie-Néonatologie du CH Remiremont (F.C.); Service de Neurologie Pédiatrique (E.C.), Hôpital des Enfants, CHU de Toulouse; Service de Neuropédiatrie (J.-C.C.), Hôpital Roger-Salengro, CHRU de Lille; Service de Neuropédiatrie (A. Defo), CH de Cayenne, Guyane; Department of Neurology (G.D.), Hospices Civils de Lyon; Lyon Neuroscience Research Center (CRNL) (G.D.), Brain Dynamics and Cognition Team (Dycog), INSERM U1028, CNRS UMR5292; Neurology Department (N. Gaillard, A. Ducros), Montpellier University Hospital; Department of Neurology (E.M.), Rouen University Hospital; Service de Neurologie (N. Guy), CHU Clermont-Ferrand; Service de Pédiatrie (S.L.), Centre Hospitalier d'Avignon; Service de Pédiatrie et Unité d'Urgence Pédiatrique (L.L.M.), Centre Hospitalier de Cornouaille, Quimper; Centre d'Evaluation et de Traitement de la Douleur dans le service de Neurochirurgie (C.L.), CHU de Lille; Service de Neurologie Centre Hospitalier de Narbonne (C.R.); Service de Neurologie Vasculaire (C. Rey), CHU Timone, Marseille; Centre de Génétique et Centre de Référence des Anomalies du Développement et Syndromes Malformatifs de l'Interrégion Est (C.T.), Centre Hospitalier Universitaire Dijon; Département de Neurologie (F.V.), Centre Hospitalier Intercommunal d'Aix-Pertuis, Aix-en-Provence; and Charles Coulomb Laboratory (A. Ducros), UMR 5221 CNRS-UM, Montpellier University, France.

Published: January 2022

Background And Objective: variants have been reported in a few cases of patients with hemiplegic migraine. To clarify the role of in familial hemiplegic migraine, we studied this gene in a large cohort of affected probands.

Methods: was analyzed in 860 probands with hemiplegic migraine, and variations were identified in 30 probands. Genotyping of relatives identified a total of 49 persons with variations whose clinical manifestations were detailed.

Results: variations were found in 12 of 163 probands who previously tested negative for , , and variations and in 18 of 697 consecutive probands screened simultaneously on the 4 genes. In this second group, pathogenic variants were found in 105 individuals, mostly in (42%), followed by (26%), 17%), and (15%). The variations included 7 distinct variants, 5 of which have already been described in persons with paroxysmal kinesigenic dyskinesia and 2 new variants. Eight probands had a deletion of the whole gene. Among the 49 patients with variations in , 26 had pure hemiplegic migraine and 16 had hemiplegic migraine associated with another manifestation: epilepsy (8), learning disabilities (5), hypersomnia (4), or abnormal movement (3). Three patients had epilepsy without migraine: 2 had paroxysmal kinesigenic dyskinesia without migraine, and 1 was asymptomatic.

Discussion: should be regarded as the fourth autosomal dominant gene for hemiplegic migraine and screened in any affected patient, together with the 3 other main genes. Further studies are needed to understand how the same loss-of-function variations can lead to a wide range of neurologic phenotypes, including paroxysmal movement disorder, epilepsy, learning disabilities, sleep disorder, and hemiplegic migraine.

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000012947DOI Listing

Publication Analysis

Top Keywords

hemiplegic migraine
32
migraine
9
hemiplegic
8
migraine associated
8
variations
8
variations clinical
8
paroxysmal kinesigenic
8
kinesigenic dyskinesia
8
epilepsy learning
8
learning disabilities
8

Similar Publications

Familial hemiplegic migraine type 2 results from pathogenic variants in the gene, which encodes for a catalytic subunit of sodium/potassium ATPase. This extremely rare autosomal dominant disorder manifests with a spectrum of symptoms, most commonly pure hemiplegic phenotype, epilepsy, and/or intellectual disability. In this study, we detail the clinical features and genetic analysis of nine patients from a large family spanning four generations, with all carrying a previously unreported likely pathogenic variant, p.

View Article and Find Full Text PDF

We present a case of suspected induced intractable headaches and paralysis after receiving an etonogestrel 68 mg implant. After extensive neurological evaluation, the etonogestrel implant was removed and neurological symptoms resolved. The case raises concerns about a potential rare risk of progestin-containing contraceptives in patients with migraines with aura warranting further investigation.

View Article and Find Full Text PDF

Introduction: ATP1A2 and CACNA1A genes encode proteins forming transmembrane channels, Na+/K+/ATPase transporter and voltage-gated calcium channel, respectively. Pathogenic variants in these genes are associated with hemiplegic migraines, movement disorders and developmental and epileptic encephalopathy.

Case Report: We report a child presenting epileptic encephalopathy with cognitive and behavioral troubles.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!